| Dr Gerald E Dworkin, DO | |
|
900 Faulke Rd Suite 200, Wilmington, DE 19803 | |
| (610) 237-5006 | |
| (610) 237-4138 |
| Full Name | Dr Gerald E Dworkin |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 43 Years |
| Location | 900 Faulke Rd Suite 200, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578673208 | NPI | - | NPPES |
| 0012030800001 | Medicaid | PA | |
| 01013952 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | OS004891L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Delaware County Memorial Hospital | Drexel hill, PA | Hospital |
| Entity Name | Physicians Rehabilitation Associates P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735278 PECOS PAC ID: 4688652845 Enrollment ID: O20040713000841 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
Body fatness was associated with more cardiovascular disease risk factors even among healthy, aerobically fit men, according to a report today in an obesity-themed issue of Circulation: Journal of the American Heart Association.
An international team of researchers from the CEA, the CNRS, the Institut Laue-Langevin, the Jülich Centre for Neutron Science, the University of California Irvine, the Australian Institute of Science and Technology Organisation, the Max Planck Institute Mülheim and the University of Perugia has shed light on the molecular mechanism behind the importance of water for functional protein dynamics.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerald E Dworkin, DO 1503 Lansdowne Ave, Darby, PA 19023 Ph: (610) 237-5006 | Dr Gerald E Dworkin, DO 900 Faulke Rd Suite 200, Wilmington, DE 19803 Ph: (610) 237-5006 |
News Archive
New research by scientists at Schepens Eye Research Institute may help explain why the anti-cancer drug Avastin, which targets a growth factor responsible for creation of new blood vessels, causes potentially fatal brain inflammation in certain patients.
Body fatness was associated with more cardiovascular disease risk factors even among healthy, aerobically fit men, according to a report today in an obesity-themed issue of Circulation: Journal of the American Heart Association.
An international team of researchers from the CEA, the CNRS, the Institut Laue-Langevin, the Jülich Centre for Neutron Science, the University of California Irvine, the Australian Institute of Science and Technology Organisation, the Max Planck Institute Mülheim and the University of Perugia has shed light on the molecular mechanism behind the importance of water for functional protein dynamics.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
› Verified 3 days ago
Dr. Jessica De Curtis Fernandez, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-5874 | |
Jason Roth, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 405 Silverside Rd Ste 104, Wilmington, DE 19809 Phone: 844-365-7246 Fax: 844-516-0080 | |
Dr. Binduben A Patel, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-2511 | |
Dr. James Francis Bonner, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 206 N Union St, Wilmington, DE 19805 Phone: 307-777-3711 Fax: 302-777-3454 | |
Andrew Bryce Bernstein, DPT, PT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1 Righter Pkwy Ste 150, Wilmington, DE 19803 Phone: 302-477-1536 | |
Dr. Barry L Bakst, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2006 Foulk Rd, Suite B, Wilmington, DE 19810 Phone: 302-529-8783 Fax: 302-529-7470 | |
Dr. Anne C Mack, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2006 Foulk Rd, Suite B, Wilmington, DE 19810 Phone: 302-529-8783 Fax: 302-529-7470 |